CRISPR Therapeutics (CRSP)
(Real Time Quote from BATS)
$56.18 USD
+1.62 (2.97%)
Updated Jul 22, 2024 03:44 PM ET
After-Market: $56.22 +0.04 (0.07%) 4:08 PM ET
1-Strong Buy of 5 1
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-1.37 | 100.00% |
Earnings Summary
For their last quarter, CRISPR Therapeutics (CRSP) reported earnings of -$1.43 per share, beating the Zacks Consensus Estimate of $-1.63 per share. This reflects a positive earnings surprise of 12.27%. Look out for CRSP's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.37 per share, reflecting a year-over-year decrease of 39.8%.
Earnings History
Price & Consensus
Zacks News for CRSP
Prime Medicine (PRME) Gains 16.4% in 3 Months: Buy Now or Wait?
CRSP: What are Zacks experts saying now?
Zacks Private Portfolio Services